Saturday, August 01, 2020 1:38:20 PM
Some interesting possibilities regarding Arrayit can be inferred from the information I compiled below-just possibilities- do not know if anything I compiled below is in the works. This is speculation only.
1 ) Arrayit was previously on list of stocks approved to offer tests under IVD as CLIA certified company. It is no longer on this list but is not in a list of companies removed from that list
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-testing-sars-cov-2#offeringtests
2)recently EUAs have been granted to companies offering flu and corona virus tests
3) https://www.nibib.nih.gov/news-events/newsroom/nih-leadership-details-unprecedented-initiative-ramp-testing-technologies-covid-19
From the above article:
“RADx Advanced Technology Platforms (RADx-ATP), will support the scale-up of more advanced technologies that can achieve immediate, substantial increases in capacity. The program uses a rapid-response application process for companies with existing point-of-care technologies authorized by the U.S. Food and Drug Administration for detecting SARS-CoV-2 that can scale production to between 20,000 and 100,000 tests per day by the fall. Additionally, RADx-ATP will seek to expand "mega-labs" across the country that can increase testing capacity to 100,000 to 250,000 tests per day.”
4)Regarding RADx criteria for companies applying for this:
https://www.poctrn.org/atp
includes CLIA certification,FDA EUA -Arrayit does not have this (hopefully we will),90%sensitivity,95% specificity), high throughput lab includes ability to do 100,000 to 250,000 cases per day by 09/20,ability to test for influenza A&B is mentioned but not required
5)Other beneficiaries if RADx have already been in the news:
https://techcrunch.com/2020/07/31/genomics-startup-helix-receives-33-million-in-nih-funding-to-scale-covid-19-testing/
This company from above article:
“The U.S. National Institutes of Health (NIH) is revealing the first beneficiaries of its Rapid Acceleration of Diagnostics (RADx) program, and San Mateo-based Helix is on the receiving end of $33 million in federal funding as a result. “
5)I am starting to believe Mark may actually be working to help the US in its crisis and hopefully charges will be dismissed as without validity
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM